<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38040125</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-7492</ISSN><JournalIssue CitedMedium="Internet"><Volume>339</Volume><PubDate><Year>2024</Year><Month>Jan</Month><Day>02</Day></PubDate></JournalIssue><Title>Virus research</Title><ISOAbbreviation>Virus Res</ISOAbbreviation></Journal><ArticleTitle>Enterovirus D68 vRNA induces type III IFN production via MDA5.</ArticleTitle><Pagination><StartPage>199284</StartPage><MedlinePgn>199284</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">199284</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.virusres.2023.199284</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0168-1702(23)00246-0</ELocationID><Abstract><AbstractText>Enterovirus D68 (EV-D68) primarily spreads through the respiratory tract and causes respiratory symptoms in children and acute flaccid myelitis (AFM). Type III interferons (IFNs) play a critical role in inhibiting viral growth in respiratory epithelial cells. However, the mechanism by which EV-D68 induces type III IFN production is not yet fully understood. In this study, we show that EV-D68 infection stimulates Calu-3 cells to secrete IFN-λ. The transfection of EV-D68 viral RNA (vRNA) stimulated IFN-λ via MDA5. Furthermore, our findings provide evidence that EV-D68 infection also induces MDA5-IRF3/IRF7-mediated IFN-λ. In addition, we discovered that EV-D68 infection downregulated MDA5 expression. Knockdown of MDA5 increased EV-D68 replication in Calu-3 cells. Finally, we demonstrated that the IFN-λ1 and IFN-λ2/3 proteins effectively inhibit EV-D68 infection in respiratory epithelial cells. In summary, our study shows that EV-D68 induces type III IFN production via the activated MDA5-IRF3/IRF7 pathway and that type III IFNs inhibit EV-D68 replication in Calu-3 cells.</AbstractText><CopyrightInformation>Copyright © 2023. Published by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chio</LastName><ForeName>Chi-Chong</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Research Center for Emerging Viral Infections, College of Medicine, Chang Gung University, Kwei-Shan, Tao-Yuan, Taiwan; Department of Medical Biotechnology and Laboratory Science, College of Medicine, Chang Gung University, Kwei-Shan, Tao-Yuan, Taiwan; Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Kwei-Shan, Tao-Yuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Hio-Wai</ForeName><Initials>HW</Initials><AffiliationInfo><Affiliation>Research Center for Emerging Viral Infections, College of Medicine, Chang Gung University, Kwei-Shan, Tao-Yuan, Taiwan; Department of Medical Biotechnology and Laboratory Science, College of Medicine, Chang Gung University, Kwei-Shan, Tao-Yuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Shih-Hsiang</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Division of Pediatric Hematology/Oncology, Linkou Chang Gung Memorial Hospital, Kwei-Shan, Tao-Yuan, Taiwan; College of Medicine, Chang Gung University, Kwei-Shan, Tao-Yuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Hsing-I</ForeName><Initials>HI</Initials><AffiliationInfo><Affiliation>Research Center for Emerging Viral Infections, College of Medicine, Chang Gung University, Kwei-Shan, Tao-Yuan, Taiwan; Department of Medical Biotechnology and Laboratory Science, College of Medicine, Chang Gung University, Kwei-Shan, Tao-Yuan, Taiwan; Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Kwei-Shan, Tao-Yuan, Taiwan; Department of Pediatrics, Linkou Chang Gung Memorial Hospital, Kwei-Shan, Tao-Yuan, Taiwan. Electronic address: hihuang@mail.cgu.edu.tw.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NSTC 111-2634-F-182-001</GrantID><Agency> National Science and Technology Council (NSTC), Taiwan </Agency><Country /></Grant><Grant><GrantID>MOST 111-2634-F-182-001</GrantID><Agency>Ministry of Science and Technology (MOST), Taiwan </Agency><Country /></Grant><Grant><GrantID>CMRPD1K0701, CMRPD1K0702, CMRPD1M0932)</GrantID><Agency> Chang Gung Memorial Hospital, Taiwan </Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Virus Res</MedlineTA><NlmUniqueID>8410979</NlmUniqueID><ISSNLinking>0168-1702</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000095022">Interferon Lambda</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030016" MajorTopicYN="Y">Enterovirus D, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000095022" MajorTopicYN="N">Interferon Lambda</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009468" MajorTopicYN="Y">Neuromuscular Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012137" MajorTopicYN="N">Respiratory System</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Calu-3</Keyword><Keyword MajorTopicYN="N">Ev-D68</Keyword><Keyword MajorTopicYN="N">IFN-λ</Keyword><Keyword MajorTopicYN="N">MDA5</Keyword><Keyword MajorTopicYN="N">vRNA</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>11</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>17</Day><Hour>13</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>2</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>1</Day><Hour>19</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38040125</ArticleId><ArticleId IdType="pmc">PMC10704515</ArticleId><ArticleId IdType="doi">10.1016/j.virusres.2023.199284</ArticleId><ArticleId IdType="pii">S0168-1702(23)00246-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124(4):783–801. doi: 10.1016/j.cell.2006.02.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2006.02.015</ArticleId><ArticleId IdType="pubmed">16497588</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayudhya S.S.N., et al. Enhanced enterovirus D68 replication in neuroblastoma cells is associated with a cell culture-adaptive amino acid substitution in VP1. mSphere. 2020;5(6) doi: 10.1128/msphere.00941-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/msphere.00941-20</ArticleId><ArticleId IdType="pmc">PMC7643833</ArticleId><ArticleId IdType="pubmed">33148825</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J., et al. Bypassing pan-enterovirus host factor PLA2G16. Nat. Commun. 2019;10(1):3171. doi: 10.1038/s41467-019-11256-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-11256-z</ArticleId><ArticleId IdType="pmc">PMC6639302</ArticleId><ArticleId IdType="pubmed">31320648</ArticleId></ArticleIdList></Reference><Reference><Citation>Barral P.M., et al. MDA-5 is cleaved in poliovirus-infected cells. J. Virol. 2007;81(8):3677–3684. doi: 10.1128/jvi.01360-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.01360-06</ArticleId><ArticleId IdType="pmc">PMC1866155</ArticleId><ArticleId IdType="pubmed">17267501</ArticleId></ArticleIdList></Reference><Reference><Citation>Batool M., Kim M.S., Choi S. Structural insights into the distinctive RNA recognition and therapeutic potentials of RIG-I-like receptors. Med. Res. Rev. 2022;42(1):399–425. doi: 10.1002/med.21845.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/med.21845</ArticleId><ArticleId IdType="pubmed">34287999</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolen C.R., et al. Dynamic expression profiling of type I and type III interferon-stimulated hepatocytes reveals a stable hierarchy of gene expression. Hepatology. 2014;59(4):1262–1272. doi: 10.1002/hep.26657.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.26657</ArticleId><ArticleId IdType="pmc">PMC3938553</ArticleId><ArticleId IdType="pubmed">23929627</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen K.-R., Ling P. Interplays between enterovirus A71 and the innate immune system. J. Biomed. Sci. 2019;26(1):95. doi: 10.1186/s12929-019-0596-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-019-0596-8</ArticleId><ArticleId IdType="pmc">PMC6886175</ArticleId><ArticleId IdType="pubmed">31787104</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiale C., Greene T.T., Zuniga E.I. Interferon induction, evasion, and paradoxical roles during SARS-CoV-2 infection*. Immunol. Rev. 2022;309(1):12–24. doi: 10.1111/imr.13113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.13113</ArticleId><ArticleId IdType="pmc">PMC9350402</ArticleId><ArticleId IdType="pubmed">35775361</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow J., Franz K.M., Kagan J.C. PRRs are watching you: localization of innate sensing and signaling regulators. Virology. 2015;479-480:104–109. doi: 10.1016/j.virol.2015.02.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2015.02.051</ArticleId><ArticleId IdType="pmc">PMC4424080</ArticleId><ArticleId IdType="pubmed">25800355</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson S., et al. IFNλ is a potent anti-influenza therapeutic without the inflammatory side effects of IFNα treatment. EMBO Mol. Med. 2016;8(9):1099–1112. doi: 10.15252/emmm.201606413.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201606413</ArticleId><ArticleId IdType="pmc">PMC5009813</ArticleId><ArticleId IdType="pubmed">27520969</ArticleId></ArticleIdList></Reference><Reference><Citation>Devries M.K., et al. Recent clinical isolates of enterovirus D68 have increased replication and induce enhanced epithelial immune response compared to the prototype fermon strain. Viruses. 2023;15(6) doi: 10.3390/v15061291.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15061291</ArticleId><ArticleId IdType="pmc">PMC10305710</ArticleId><ArticleId IdType="pubmed">37376591</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Q., et al. Enterovirus 2Apro targets MDA5 and MAVS in infected cells. J. Virol. 2014;88(6):3369–3378. doi: 10.1128/jvi.02712-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.02712-13</ArticleId><ArticleId IdType="pmc">PMC3957915</ArticleId><ArticleId IdType="pubmed">24390337</ArticleId></ArticleIdList></Reference><Reference><Citation>Filipe I.C., et al. Comparison of tissue tropism and host response to enteric and respiratory enteroviruses. PLoS Pathog. 2022;18(7) doi: 10.1371/journal.ppat.1010632.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010632</ArticleId><ArticleId IdType="pmc">PMC9286751</ArticleId><ArticleId IdType="pubmed">35789345</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman M.C., et al. Respiratory and intestinal epithelial cells exhibit differential susceptibility and innate immune responses to contemporary EV-D68 isolates. Elife. 2021;10:e66687. doi: 10.7554/eLife.66687.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.66687</ArticleId><ArticleId IdType="pmc">PMC8285104</ArticleId><ArticleId IdType="pubmed">34196272</ArticleId></ArticleIdList></Reference><Reference><Citation>Galani I.E., et al. Interferon-λ mediates non-redundant front-line antiviral protection against influenza virus infection without compromising host fitness. Immunity. 2017;46(5):875–890. doi: 10.1016/j.immuni.2017.04.025. e6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2017.04.025</ArticleId><ArticleId IdType="pubmed">28514692</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilbert C., et al. Age-related expression of IFN-λ1 versus IFN-I and beta-defensins in the nasopharynx of SARS-CoV-2-infected individuals. Front. Immunol. 2021;12 doi: 10.3389/fimmu.2021.750279.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.750279</ArticleId><ArticleId IdType="pmc">PMC8631500</ArticleId><ArticleId IdType="pubmed">34858406</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong Y.N., et al. Molecular evolution and the global reemergence of enterovirus D68 by genome-wide analysis. Med. (Baltimore) 2016;95(31):e4416. doi: 10.1097/md.0000000000004416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/md.0000000000004416</ArticleId><ArticleId IdType="pmc">PMC4979813</ArticleId><ArticleId IdType="pubmed">27495059</ArticleId></ArticleIdList></Reference><Reference><Citation>Good C., Wells A.I., Coyne C.B. Type III interferon signaling restricts enterovirus 71 infection of goblet cells. Sci. Adv. 2019;5(3):eaau4255. doi: 10.1126/sciadv.aau4255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aau4255</ArticleId><ArticleId IdType="pmc">PMC6402847</ArticleId><ArticleId IdType="pubmed">30854425</ArticleId></ArticleIdList></Reference><Reference><Citation>Han L., et al. SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways. J. Med. Virol. 2021;93(9):5376–5389. doi: 10.1002/jmv.27050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27050</ArticleId><ArticleId IdType="pmc">PMC8242602</ArticleId><ArticleId IdType="pubmed">33913550</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemann E.A., Gale M., Jr., Savan R. Interferon lambda genetics and biology in regulation of viral control. Front. Immunol. 2017;8:1707. doi: 10.3389/fimmu.2017.01707.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01707</ArticleId><ArticleId IdType="pmc">PMC5723907</ArticleId><ArticleId IdType="pubmed">29270173</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H.I., Lin J.Y., Chen S.H. EV71 infection induces IFNβ expression in neural cells. Viruses. 2019;11(12) doi: 10.3390/v11121121.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11121121</ArticleId><ArticleId IdType="pmc">PMC6950376</ArticleId><ArticleId IdType="pubmed">31817126</ArticleId></ArticleIdList></Reference><Reference><Citation>Imamura T., et al. Antigenic and receptor binding properties of enterovirus 68. J. Virol. 2014;88(5):2374–2384. doi: 10.1128/jvi.03070-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.03070-13</ArticleId><ArticleId IdType="pmc">PMC3958110</ArticleId><ArticleId IdType="pubmed">24371050</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivashkiv L.B., Donlin L.T. Regulation of type I interferon responses. Nat. Rev. Immunol. 2014;14(1):36–49. doi: 10.1038/nri3581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3581</ArticleId><ArticleId IdType="pmc">PMC4084561</ArticleId><ArticleId IdType="pubmed">24362405</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato H., et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature. 2006;441(7089):101–105. doi: 10.1038/nature04734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04734</ArticleId><ArticleId IdType="pubmed">16625202</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 2010;11(5):373–384. doi: 10.1038/ni.1863.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.1863</ArticleId><ArticleId IdType="pubmed">20404851</ArticleId></ArticleIdList></Reference><Reference><Citation>Klinkhammer J., et al. IFN-λ prevents influenza virus spread from the upper airways to the lungs and limits virus transmission. Elife. 2018;7 doi: 10.7554/eLife.33354.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.33354</ArticleId><ArticleId IdType="pmc">PMC5953542</ArticleId><ArticleId IdType="pubmed">29651984</ArticleId></ArticleIdList></Reference><Reference><Citation>Kouwaki T., et al. RIG-I-like receptor-mediated recognition of viral genomic RNA of severe acute respiratory syndrome coronavirus-2 and viral escape from the host innate immune responses. Front. Immunol. 2021;12 doi: 10.3389/fimmu.2021.700926.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.700926</ArticleId><ArticleId IdType="pmc">PMC8267574</ArticleId><ArticleId IdType="pubmed">34249006</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazear H.M., Schoggins J.W., Diamond M.S. Shared and distinct functions of type I and type III interferons. Immunity. 2019;50(4):907–923. doi: 10.1016/j.immuni.2019.03.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2019.03.025</ArticleId><ArticleId IdType="pmc">PMC6839410</ArticleId><ArticleId IdType="pubmed">30995506</ArticleId></ArticleIdList></Reference><Reference><Citation>Messacar K., et al. Enterovirus D68 and acute flaccid myelitis-evaluating the evidence for causality. Lancet Infect. Dis. 2018;18(8):e239–e247. doi: 10.1016/s1473-3099(18)30094-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1473-3099(18)30094-x</ArticleId><ArticleId IdType="pmc">PMC6778404</ArticleId><ArticleId IdType="pubmed">29482893</ArticleId></ArticleIdList></Reference><Reference><Citation>Midgley C.M., et al. Severe respiratory illness associated with enterovirus D68 - missouri and Illinois, 2014. MMWR Morb. Mortal. Wkly Rep. 2014;63(36):798–799.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4584696</ArticleId><ArticleId IdType="pubmed">25211545</ArticleId></ArticleIdList></Reference><Reference><Citation>Miknis Z.J., et al. Crystal structure of human interferon-λ1 in complex with its high-affinity receptor interferon-λR1. J. Mol. Biol. 2010;404(4):650–664. doi: 10.1016/j.jmb.2010.09.068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2010.09.068</ArticleId><ArticleId IdType="pmc">PMC2991516</ArticleId><ArticleId IdType="pubmed">20934432</ArticleId></ArticleIdList></Reference><Reference><Citation>Mordstein M., et al. Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J. Virol. 2010;84(11):5670–5677. doi: 10.1128/jvi.00272-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00272-10</ArticleId><ArticleId IdType="pmc">PMC2876583</ArticleId><ArticleId IdType="pubmed">20335250</ArticleId></ArticleIdList></Reference><Reference><Citation>Negishi H., Taniguchi T., Yanai H. The interferon (IFN) class of cytokines and the IFN regulatory factor (IRF) transcription factor family. Cold Spring Harb. Perspect. Biol. 2018;10(11) doi: 10.1101/cshperspect.a028423.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a028423</ArticleId><ArticleId IdType="pmc">PMC6211389</ArticleId><ArticleId IdType="pubmed">28963109</ArticleId></ArticleIdList></Reference><Reference><Citation>Olagnier D., Hiscott J. Type I and type III interferon-induced immune response: it's a matter of kinetics and magnitude. Hepatology. 2014;59(4):1225–1228. doi: 10.1002/hep.26959.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.26959</ArticleId><ArticleId IdType="pubmed">24677190</ArticleId></ArticleIdList></Reference><Reference><Citation>Parsons K.S., Hsu A.C., Wark P.A.B. TLR3 and MDA5 signalling, although not expression, is impaired in asthmatic epithelial cells in response to rhinovirus infection. Clin. Experim. Allergy. 2014;44(1):91–101. doi: 10.1111/cea.12218.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cea.12218</ArticleId><ArticleId IdType="pubmed">24131248</ArticleId></ArticleIdList></Reference><Reference><Citation>Pervolaraki K., et al. Differential induction of interferon stimulated genes between type I and type III interferons is independent of interferon receptor abundance. PLoS Pathog. 2018;14(11) doi: 10.1371/journal.ppat.1007420.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007420</ArticleId><ArticleId IdType="pmc">PMC6287881</ArticleId><ArticleId IdType="pubmed">30485383</ArticleId></ArticleIdList></Reference><Reference><Citation>Pott J., et al. IFN-lambda determines the intestinal epithelial antiviral host defense. Proc. Natl. Acad. Sci. U S A, 2011;108(19):7944–7949. doi: 10.1073/pnas.1100552108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1100552108</ArticleId><ArticleId IdType="pmc">PMC3093475</ArticleId><ArticleId IdType="pubmed">21518880</ArticleId></ArticleIdList></Reference><Reference><Citation>Reis G., et al. Early treatment with pegylated interferon lambda for Covid-19. New Engl. J. Med. 2023;388(6):518–528. doi: 10.1056/NEJMoa2209760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2209760</ArticleId><ArticleId IdType="pmc">PMC9933926</ArticleId><ArticleId IdType="pubmed">36780676</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowan-Nash A.D., et al. Cross-domain and viral interactions in the microbiome. Microbiol. Mol. Biol. Rev. 2019;83(1) doi: 10.1128/MMBR.00044-18. e00044-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MMBR.00044-18</ArticleId><ArticleId IdType="pmc">PMC6383444</ArticleId><ArticleId IdType="pubmed">30626617</ArticleId></ArticleIdList></Reference><Reference><Citation>Rui Y., et al. Disruption of MDA5-mediated innate immune responses by the 3C proteins of coxsackievirus A16, coxsackievirus A6, and enterovirus D68. J. Virol. 2017;91(13) doi: 10.1128/jvi.00546-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00546-17</ArticleId><ArticleId IdType="pmc">PMC5469270</ArticleId><ArticleId IdType="pubmed">28424289</ArticleId></ArticleIdList></Reference><Reference><Citation>Schieble J.H., Fox V.L., Lennette E.H. A probable new human picornavirus associated with respiratory diseases. Am. J. Epidemiol. 1967;85(2):297–310. doi: 10.1093/oxfordjournals.aje.a120693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a120693</ArticleId><ArticleId IdType="pubmed">4960233</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster J.E., et al. Severe enterovirus 68 respiratory illness in children requiring intensive care management. J. Clin. Virol. 2015;70:77–82. doi: 10.1016/j.jcv.2015.07.298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2015.07.298</ArticleId><ArticleId IdType="pubmed">26305825</ArticleId></ArticleIdList></Reference><Reference><Citation>Selvaggi C., et al. Interferon lambda 1-3 expression in infants hospitalized for RSV or HRV associated bronchiolitis. J. Infect. 2014;68(5):467–477. doi: 10.1016/j.jinf.2013.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2013.12.010</ArticleId><ArticleId IdType="pmc">PMC7172705</ArticleId><ArticleId IdType="pubmed">24389019</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheppard P., et al. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat. Immunol. 2003;4(1):63–68. doi: 10.1038/ni873.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni873</ArticleId><ArticleId IdType="pubmed">12469119</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin H., et al. Intranasal inoculation of IFN-λ resolves SARS-CoV-2 lung infection via the rapid reduction of viral burden and improvement of tissue damage. Front. Immunol. 2022;13 doi: 10.3389/fimmu.2022.1009424.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1009424</ArticleId><ArticleId IdType="pmc">PMC9744928</ArticleId><ArticleId IdType="pubmed">36524125</ArticleId></ArticleIdList></Reference><Reference><Citation>Sommereyns C., et al. IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog. 2008;4(3) doi: 10.1371/journal.ppat.1000017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000017</ArticleId><ArticleId IdType="pmc">PMC2265414</ArticleId><ArticleId IdType="pubmed">18369468</ArticleId></ArticleIdList></Reference><Reference><Citation>Sposito B., et al. The interferon landscape along the respiratory tract impacts the severity of COVID-19. Cell. 2021;184(19):4953–4968. doi: 10.1016/j.cell.2021.08.016. e16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.08.016</ArticleId><ArticleId IdType="pmc">PMC8373821</ArticleId><ArticleId IdType="pubmed">34492226</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanifer M.L., et al. Importance of type I and III interferons at respiratory and intestinal barrier surfaces. Front. Immunol. 2020;11 doi: 10.3389/fimmu.2020.608645.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.608645</ArticleId><ArticleId IdType="pmc">PMC7759678</ArticleId><ArticleId IdType="pubmed">33362795</ArticleId></ArticleIdList></Reference><Reference><Citation>Su R., et al. The TLR3/IRF1/Type III IFN axis facilitates antiviral responses against enterovirus infections in the intestine. MBio. 2020;11(6) doi: 10.1128/mBio.02540-20. e02540-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.02540-20</ArticleId><ArticleId IdType="pmc">PMC7683398</ArticleId><ArticleId IdType="pubmed">33203755</ArticleId></ArticleIdList></Reference><Reference><Citation>Walter M.R. The role of structure in the biology of interferon signaling. Front. Immunol. 2020;11 doi: 10.3389/fimmu.2020.606489.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.606489</ArticleId><ArticleId IdType="pmc">PMC7689341</ArticleId><ArticleId IdType="pubmed">33281831</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan Q., et al. MDA5 induces a stronger interferon response than RIG-I to GCRV infection through a mechanism involving the phosphorylation and dimerization of IRF3 and IRF7 in CIK cells. Front. Immunol. 2017;8 doi: 10.3389/fimmu.2017.00189.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.00189</ArticleId><ArticleId IdType="pmc">PMC5323377</ArticleId><ArticleId IdType="pubmed">28286505</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei W., et al. ICAM-5/telencephalin is a functional entry receptor for enterovirus D68. Cell Host. Microbe. 2016;20(5):631–641. doi: 10.1016/j.chom.2016.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2016.09.013</ArticleId><ArticleId IdType="pubmed">27923705</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells A.I., Coyne C.B. Enteroviruses: a gut-wrenching game of entry, detection, and evasion. Viruses. 2019;11(5) doi: 10.3390/v11050460.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11050460</ArticleId><ArticleId IdType="pmc">PMC6563291</ArticleId><ArticleId IdType="pubmed">31117206</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu B., et al. Structural basis for dsRNA recognition, filament formation, and antiviral signal activation by MDA5. Cell. 2013;152(1–2):276–289. doi: 10.1016/j.cell.2012.11.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.11.048</ArticleId><ArticleId IdType="pubmed">23273991</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi C., et al. Influenza A virus PA antagonizes interferon-β by interacting with interferon regulatory factor 3. Front. Immunol. 2017;8:1051. doi: 10.3389/fimmu.2017.01051.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01051</ArticleId><ArticleId IdType="pmc">PMC5600993</ArticleId><ArticleId IdType="pubmed">28955326</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X., et al. Human intestinal organoids recapitulate enteric infections of enterovirus and coronavirus. Stem. Cell. Rep. 2021;16(3):493–504. doi: 10.1016/j.stemcr.2021.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2021.02.009</ArticleId><ArticleId IdType="pmc">PMC7940440</ArticleId><ArticleId IdType="pubmed">33626333</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>